BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33412162)

  • 1. Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis.
    Li Q; Gulati A; Lemaire M; Nottoli T; Bale A; Tufro A
    Kidney Int; 2021 May; 99(5):1102-1117. PubMed ID: 33412162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. My, oh, MYO9A! Just how complex can regulation of the podocyte actin cytoskeleton get?
    Schlöndorff JS
    Kidney Int; 2021 May; 99(5):1065-1067. PubMed ID: 33892856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First identification of
    Lin FJ; Yao L; Hu XQ; Bian F; Ji G; Jiang GR; Gale DP; Ren HQ
    Clin Sci (Lond); 2019 Jan; 133(1):9-21. PubMed ID: 30523047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis.
    Akilesh S; Suleiman H; Yu H; Stander MC; Lavin P; Gbadegesin R; Antignac C; Pollak M; Kopp JB; Winn MP; Shaw AS
    J Clin Invest; 2011 Oct; 121(10):4127-37. PubMed ID: 21911940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
    Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
    J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-Nitrosylation of RhoGAP Myosin9A Is Altered in Advanced Diabetic Kidney Disease.
    Li Q; Veron D; Tufro A
    Front Med (Lausanne); 2021; 8():679518. PubMed ID: 34336885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Mutation of Coenzyme Q
    Song CC; Hong Q; Geng XD; Wang X; Wang SQ; Cui SY; Guo MD; Li O; Cai GY; Chen XM; Wu D
    Chin Med J (Engl); 2018 Nov; 131(22):2666-2675. PubMed ID: 30425193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.
    Gbadegesin RA; Hall G; Adeyemo A; Hanke N; Tossidou I; Burchette J; Wu G; Homstad A; Sparks MA; Gomez J; Jiang R; Alonso A; Lavin P; Conlon P; Korstanje R; Stander MC; Shamsan G; Barua M; Spurney R; Singhal PC; Kopp JB; Haller H; Howell D; Pollak MR; Shaw AS; Schiffer M; Winn MP
    J Am Soc Nephrol; 2014 Sep; 25(9):1991-2002. PubMed ID: 24676636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho GAP myosin IXa is a regulator of kidney tubule function.
    Thelen S; Abouhamed M; Ciarimboli G; Edemir B; Bähler M
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F501-13. PubMed ID: 26136556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury.
    Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR
    Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.
    Weng PL; Majmundar AJ; Khan K; Lim TY; Shril S; Jin G; Musgrove J; Wang M; Ahram DF; Aggarwal VS; Bier LE; Heinzen EL; Onuchic-Whitford AC; Mann N; Buerger F; Schneider R; Deutsch K; Kitzler TM; Klämbt V; Kolb A; Mao Y; Moufawad El Achkar C; Mitrotti A; Martino J; Beck BB; Altmüller J; Benz MR; Yano S; Mikati MA; Gunduz T; Cope H; Shashi V; ; Trachtman H; Bodria M; Caridi G; Pisani I; Fiaccadori E; AbuMaziad AS; Martinez-Agosto JA; Yadin O; Zuckerman J; Kim A; ; John-Kroegel U; Tyndall AV; Parboosingh JS; Innes AM; Bierzynska A; Koziell AB; Muorah M; Saleem MA; Hoefele J; Riedhammer KM; Gharavi AG; Jobanputra V; Pierce-Hoffman E; Seaby EG; O'Donnell-Luria A; Rehm HL; Mane S; D'Agati VD; Pollak MR; Ghiggeri GM; Lifton RP; Goldstein DB; Davis EE; Hildebrandt F; Sanna-Cherchi S
    Am J Hum Genet; 2021 Feb; 108(2):357-367. PubMed ID: 33508234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiology of focal segmental glomerulosclerosis: new developments.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
    Michaud JL; Chaisson KM; Parks RJ; Kennedy CR
    Kidney Int; 2006 Sep; 70(6):1054-61. PubMed ID: 16837921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal segmental glomerulosclerosis and proteinuria associated with Myo1E mutations: novel variants and histological phenotype analysis.
    Krendel M; Leh S; Garone ME; Edwards-Richards A; Lin JJ; Brackman D; Knappskog P; Mikhailov A
    Pediatr Nephrol; 2023 Feb; 38(2):439-449. PubMed ID: 35723736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis.
    Xie J; Hao X; Azeloglu EU; Ren H; Wang Z; Ma J; Liu J; Ma X; Wang W; Pan X; Zhang W; Zhong F; Li Y; Meng G; Kiryluk K; He JC; Gharavi AG; Chen N
    Kidney Int; 2015 Sep; 88(3):593-604. PubMed ID: 26039629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.